Alnylam Pharmaceuticals (NASDAQ:ALNY): A Value Stock Worthy of Investor Attention
Decent Value screen flags Alnylam Pharmaceuticals (ALNY) for strong growth, solid profitability, and reasonable forward valuation.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: ChartMill